SeqOnce BioSciences, Inc. — Form D
SeqOnce BioSciences, Inc. of PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-27. The offering totals $1.2M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-27
- Form: D
- Accession: 0001655808-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.0M
- Remaining: $210K
- Investors: 12
- Date of first sale: 2018-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311199
Issuer
- Name: SeqOnce BioSciences, Inc.
- CIK: 0001655808
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2265 E. FOOTHILL BOULEVARD, PASADENA, CA, 91107
- Phone: 626-765-3894
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael Giardello | Director | Pasadena, CA |
| Christopher Angermayer | Director | Pasadena, CA |
| Christopher Angermayer | Executive Officer | Pasadena, CA |
| Joseph Dunham | Director | Pasadena, CA |
Other filings by this issuer (1)
More